Histoplasmosis is a major cause of endemic mycosis worldwide. Immunosuppressed patients tend to present severe systemic disease. 1 We herein report a case of an immunocompromised patient with adult onset Still´s disease (AOSD) who, interestingly, developed a probable primary cutaneous histoplasmosis (PCH).
The patient, a 44-year-old white female, has presented features compatible with AOSD since February 2011 (spiking fever, morbilliform rash, arthromialgia, cervical lymphadenopathy, pleuropericarditis, leukocytosis, hemolytic anemia and hyperferritinemia). The bone-marrow biopsy showed no malignancy. While on use of prednisone 35 mg and leflunomide 20 mg daily, in December 2011, the patient developed a non-tender deep ulceration of 2.5 cm in the posteromedial aspect of the left lower limb (Figure 1 ). The patient reported to live near a chicken farm. The ulcer was not responsive to cephalosporin, and a skin biopsy was carried out. The histological findings included a lymphocytic and neutrophilic infiltrate with foci of necrosis; spores of Histoplasma capsulatum were seen on direct mycological exam (Grocott staining showing black intracitoplasmatic structures in macrophages ( Figure 2 ). The chest radiogram was normal. Abdominal echography was unremarkable. Serum levels of sodium, potassium, creatinine and liver enzymes were all normal. Leflunomide was then withdrawn. After 6 months of therapy with itraconazol 300 mg daily, the skin ulcer healed. The patient has been monitored for about 18 months now, with no recurrence or other feature of histoplasmosis.
Histoplasmosis is an opportunistic infection in compromised T-cells hosts. Hematogenous dissemi- 2 In our immunocompromised patient with AOSD, a disseminated form of histoplasmosis would be a more plausible presentation, but unexpectedly a PCH turned out to be probably the case.
PCH, first described by Curtis & Cawley in 1947 , is a very rare form of histoplasmosis. It is meant to occur by direct implantation of the agent into the skin. 3 Although PCH has been well described in immunocompetent individuals, an increasing number of reports have accounted for the occurrence of PCH in immunocompromised adults, including in cases of diabetes mellitus. [4] [5] [6] The only description of PCH in a rheumatic autoimmune disorder dates from 2000, when a patient with rheumatoid arthritis on longstanding corticotherapy developed, like the patient in this study, an ulcerative form of the disease. 7 Thus, this may probably be the first case of PCH in an immunocompromised patient with AOSD. AOSD was confirmed by the presence of distinctive clinical and laboratory features in our patient. 8 The PCH-related skin ulcer appeared during immunosuppressive therapy with steroids and leflunomide.
Knowingly, cutaneous lesions related to histoplasmosis usually occur by hematogenic dissemination, and a quarter of patients with systemic disease have, as seen in our patient, normal chest radiogram. Therefore, mucocutaneous manifestations should be considered, at least initially, as part of a disseminated form of the disease.
9 Indeed, the classification of cutaneous histoplasmosis in primary or secondary to subclinical systemic disease can be very subtle, as shown in a recent case report. 10 We emphasize, nevertheless, that our patient with cutaneous ulcer showed no obvious features of systemic histoplasmosis. Long duration therapy with itraconazol was highly effective.
Of interest, direct mycological analysis of the skin specimen using the Grocott stain was confirmatory for histoplasmosis in our patient. Even though a nested polymerase chain reaction (PCR) has been reported as a highly effective method for early diagnosis of histoplasmosis in HIV positive patients, the Grocott stain was as sensitive as the nested PCR for detection of Histoplasma capsulatum in spleen of infected mice. 11, 12 In summary, we here describe a case of probable PCH in a patient with AOSD using steroids and leflunomide. An increasing number of cases of PCH are being reported in patients with immunodeficiency or under immunosuppressive therapy. We bring the need for histological and mycological examination of suspicious skin lesions in patients under these circumstances. q 
